Overall survival (OS) and Hazard Ratio (HR) analyses were conducted within a pan-cancer framework to assess the impact and the putative clinical significance of the co-expression of the PEBP1 and STK11 transcripts. The gene discussed is PEBP1; the disease is cancer.